BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)

Lobbying for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 22, 2025

Expenses

$130,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

HOUSE OF REPRESENTATIVES
Natl Institutes of Health (NIH)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 9

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
HR 379
Healthcare Freedom and Choice Act
HR 483
Health Care Efficiency Through Flexibility Act
HR 1509
Accelerating Kids’ Access to Care Act of 2025
HR 1262
Mikaela Naylon Give Kids a Chance Act
HR 2528
Association Health Plans Act
HR 247
Health Care Affordability Act of 2025
HR 801
Charitable Act

Lobbying activity 5

Budget/Appropriations

HR 1968, FY2025 Full-Year Continuing Appropriations and Extensions Act; HConRes 14, Concurrent Resolution on the Budget FY2025; Potential legislation funding the Department of Defense for FY26

Health Issues

HR 379, Healthcare Freedom and Choice Act; HR 483, Health Care Efficiency through Flexibility Act; HR 1509/S 752, Accelerating Kids' Access to Care Act; HR 1262/S 932, Give Kids a Chance Act; HR 2528, Association Health Plans Act; Draft legislation related to promoting investment in pediatric cancer drug development; Draft legislation related to promoting access to clinical trials; Pharmacy Benefit Manager reforms; Anti-competitive contracting reforms; CFPB medical debt regulations;

Medicare/Medicaid

Preventing federal funding and benefit cuts to Medicaid; Site-neutral payment reforms in Medicaid;

Medical/Disease Research/Clinical Labs

Preventing Executive Branch rescissions and suspensions of NIH grants/grant funds; Education re the importance of staff roles within health agencies

Taxation/Internal Revenue Code

HR 247/S 46, the Health Care Affordability Act; HR 801/S 317, Charitable Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.